Trial NCT01721317

View at ClinicalTrials.gov 
Org. Study IDs: 116878
Secondary IDs: 2012-003105-10

Last trial update was posted on 2020-12-30

MeSH Interventions

Ezogabine

MeSH Conditions

Seizures

Other Conditions


Stopping Reasons

After reevaluation of the benefit: risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID